New Cancer Therapies Likely Following 'Orphan' Sleep Drug Findings
An inexpensive orphan drug used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies. The findings are published in the Proceedings of the National Academy of Sciences. A research team led by corresponding author Carla Grandori, M.D., Ph.D... (Source: Health News from Medical News Today)

Kasha or state selective behavior in the photochemistry of ortho-nitrobenzaldehyde?
Photochem. Photobiol. Sci., 2012, Advance ArticleDOI: 10.1039/C2PP25057H, PaperT. Schmierer, G. Ryseck, T. Villnow, N. Regner, P. GilchThe title compound undergoes ultrafast hydrogen transfer upon photo absorption. Femtosecond spectroscopy shows that yields and time constants of this process are virtually not affected when tuning the excitation wavelength over a broad range.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Photochem. Photobiol. Sci. latest articles)